SinigrinSinigrin
MedChemExpress (MCE)
HY-N0404
3952-98-5
99.92%
4°C, sealed storage, away from moisture and light *In solvent : -80°C, 6 months
-20°C, 1 month (sealed storage, away from moisture and light)
Room temperature in continental US
may vary elsewhere.
Sinigrin is a major glucosinolate present in plants of the Brassicaceae family. Sinigrin inhibits early-stage adipogenesis of 3T3-L1 adipocytes through the AMPK and MAPK signaling pathways. Sinigrin has potent anti-oxidant, anti-tumor and anti-inflammatory effects.
Sinigrin (100 μg/mL
24 H) arrestsd cells in the G0/G1phase of the cell cycle and increased the expression of p21 and p27[1]. Sinigrin (1-100 μg/mL
8 days) remarkably inhibits the accumulation of lipid droplets and adipogenesis by downregulating the expression of C/EBPα, PPARγ, leptin and aP2. Sinigrin increases the phosphorylation of AMPK, MAPK and acetyl-CoA carboxylase (ACC) in the early stage of adipocyte differentiation, suggesting that sinigrin has anti-adipogenic effects through AMPK, MAPK and ACC activation[1]. Sinigrin (1-100 μg/mL
8 days) inhibits the production of pro-inflammatory cytokines including TNF-α and IL-6, IL-1β and IL-18[1].
Sinigrin (15-30 mg/kg
Oral administration
for 12 days) exerts protective and therapeutic effects on DSS‑induced colitis, by enhancing the anti-oxidant enzymes and suppressing the intestinal inflammatory cascade of markers by regulating the MAPK pathway[2].
| | | |
| | | | | |
[1]. Lee HW, et al. Inhibitory effect of sinigrin on adipocyte differentiation in 3T3-L1 cells: Involvement of AMPK and MAPK pathways. Biomed Pharmacother. 2018 Jun
102:670-680. [Content Brief]
[2]. Rama Satya Sri Kotipalli, et al. Sinigrin Attenuates the Dextran Sulfate Sodium-induced Colitis in Mice by Modulating the MAPK Pathway. Inflammation. 2023 Jun
46(3):787-807. [Content Brief]